Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Qvist

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|August 17, 2006
An update on biomarkers of bone turnover and their utility in biomedical research and clinical practiceD J Leeming, P Alexandersen, M A Karsdal, et al.
Bone|September 15, 2001
Collagen type II C-telopeptide fragments as an index of cartilage degradationS Christgau, P Garnero, C Fledelius, et al.
Digestion|January 12, 2002
Sensory and biomechanical responses to distension of the normal human rectum and sigmoid colonP Petersen, C Gao, P Rössel, et al.
Osteoarthritis and Cartilage|February 28, 2006
The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseasesS Oestergaard, L Chouinard, N Doyle, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2009
Is bone quality associated with collagen age?D J Leeming, K Henriksen, I Byrjalsen, et al.
Bone|April 25, 2000
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapyS Christgau, O Bitsch-Jensen, N Hanover Bjarnason, et al.
Biomarkers in Cancer|November 2, 2013
Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related MarkersD J Leeming, M Koizumi, P Qvist, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2003
Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronateC Christiansen, L B Tankó, L Warming, et al.
Clinical Chemistry|November 4, 1998
Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptidesS Christgau, C Rosenquist, P Alexandersen, et al.
Scandinavian Journal of Immunology|February 12, 2008
Evaluation of cartilage and bone degradation in a murine collagen antibody-induced arthritis modelS Oestergaard, K E Rasmussen, N Doyle, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|August 17, 2006
An update on biomarkers of bone turnover and their utility in biomedical research and clinical practiceD J Leeming, P Alexandersen, M A Karsdal, et al.
Bone|September 15, 2001
Collagen type II C-telopeptide fragments as an index of cartilage degradationS Christgau, P Garnero, C Fledelius, et al.
Digestion|January 12, 2002
Sensory and biomechanical responses to distension of the normal human rectum and sigmoid colonP Petersen, C Gao, P Rössel, et al.
Osteoarthritis and Cartilage|February 28, 2006
The utility of measuring C-terminal telopeptides of collagen type II (CTX-II) in serum and synovial fluid samples for estimation of articular cartilage status in experimental models of destructive joint diseasesS Oestergaard, L Chouinard, N Doyle, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 31, 2009
Is bone quality associated with collagen age?D J Leeming, K Henriksen, I Byrjalsen, et al.
Bone|April 25, 2000
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapyS Christgau, O Bitsch-Jensen, N Hanover Bjarnason, et al.
Biomarkers in Cancer|November 2, 2013
Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related MarkersD J Leeming, M Koizumi, P Qvist, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 28, 2003
Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronateC Christiansen, L B Tankó, L Warming, et al.
Clinical Chemistry|November 4, 1998
Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptidesS Christgau, C Rosenquist, P Alexandersen, et al.
Scandinavian Journal of Immunology|February 12, 2008
Evaluation of cartilage and bone degradation in a murine collagen antibody-induced arthritis modelS Oestergaard, K E Rasmussen, N Doyle, et al.
Pageof 6